Background

Win Lei worked as a medical doctor in her early career years, involved in primary health care and HIV service delivery to vulnerable and marginalised populations. Win Lei specialised in gender, health and research methodologies during her Master of Public Health course at the University of Melbourne. Her area of expertise is qualitative research, including participatory learning and action tools.

Win Lei joined Burnet Institute in October 2016 and works in the Disease Elimination Program. She worked on the Accelerating HIV Testing and ART Initiating Among Infants study which was a cluster randomised controlled stepped-wedged study applying mixed method approaches. Currently, she works on hepatitis C projects in Myanmar and undertakes the qualitative research.

She has strong interests in infectious diseases, mixed method studies, gender, and health services research.

Positions

• Oct 2016 - present: Clinical Services Manager, Burnet Institute
• Jan 2013 - Dec 2014: Protection Specialist, World Vision International Myanmar
• Nov 2010 - Dec 2012: Medical Doctor/Clinic Manager, Medecins Sans Frontieres-Holland
• June 2008 - Nov 2010: Medical Officer, New Humanity FOCSIV Myanmar

Qualifications

• 2016: Master of Public Health, University of Melbourne, Australia)
• 2010: Diploma in Social Work, Yangon University, Myanmar
• 2007: M.B., B.S, Institute of Medicine 1, Yangon, Myanmar

Awards

• Crockett-Murphy Travel Award (2020)
• Gilead Public Health Award (2019)
• Crockett-Murphy Travel Award (2018)
• Scholarship recipient to International AIDS Conference 2018 (2018)
• Australia Awards Scholarship (2014)

Projects (1)

Current (1)

• 

  Hepatitis C: Community Testing and Treatment (CT2)

Publications (6)

2022 (3)

• Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: a qualitative study.
  Yee WL, Draper B, Myint KT, Min W, Htay H, O'Keefe D, Hellard M
  Harm Reduct J. 2022 Sep; 19(1):107
• Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up.
  Draper BL, Yee WL, Shilton S, Bowring A, Htay H, Nwe N, Markby J, Kyi KP, Easterbrook P, Naing W, Win TM, Aung KS, Howell J, Pedrana A, Hellard M
  BMJ Open. 2022 May; 12(5):e059639
• Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients.
  Draper B, Yee WL, Pedrana A, Kyi KP, Qureshi H, Htay H, Naing W, Thompson AJ, Hellard M, Howell J
  Lancet Reg Health West Pac. 2022 Mar; 20:100359

2021 (2)

• Operational experiences associated with the implementation of near point-of-care early infant diagnosis of HIV in Myanmar: a qualitative study.
  Yee WL, Htay H, Mohamed Y, Nightingale CE, Tin HH, Thein W, Kyaw LL, Yee WW, Aye MM, Badman SG, Vallely AJ, Anderson D, Kelly-Hanku A, Luchters S
  BMC Health Serv Res. 2021 Aug; 21(1):863
• Outcomes of the CT2 Study: A 'one-stop-shop' for community-based hepatitis C testing and treatment in Yangon, Myanmar.
  Draper B, Htay H, Pedrana A, Yee WL, Howell J, Kyi KP, Naing W, Aung KS, Markby J, Easterbrook P, Bowring A, Aung W, Sein YY, Nwe N, Myint KT, Shilton S, Hellard M
  Liver Int. 2021 Jun; 41(11):2578-2589

2020 (1)

• Caregiver experience and perceived acceptability of a novel near point-of-care early infant HIV diagnostic test among caregivers enrolled in the PMTCT program, Myanmar: A qualitative study.
  Yee WL, Than KK, Mohamed Y, Htay H, Tin HH, Thein W, Kyaw LL, Yee WW, Aye MM, Badman SG, Vallely AJ, Luchters S, Kelly-Hanku A; AAMI study group
  PLoS One. 2020 Oct; 15(10):e0241245